House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: A double-blind, placebo-controlled study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 4, 2000, Pages 369-375

  Guez, S ^a   Vatrinet, C ^b   Fadel, R ^b   André, Claude ^b  

^a Assoc for the Prom of A   (France)

^b Stallergenes SA   (France)

Author keywords

House dust mite; Perennial rhinitis; Sublingual immunotherapy

Indexed keywords

BETAMETHASONE; CETIRIZINE; FLUNISOLIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; EXPOSURE; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PERENNIAL RHINITIS; PRIORITY JOURNAL; SAFETY; SENSITIZATION; SKIN SENSITIVITY;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHILD; DEGLUTITION; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MITES; RHINITIS, ALLERGIC, PERENNIAL; SKIN TESTS; TREATMENT OUTCOME;

EID: 0034109759     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00413.x     Document Type: Article

References (25)

1. 1. SPORIK R, CHAPMAN MD, PLATTS-MILLS TAE. House dust mite exposure as a cause of asthma. Clin Exp Allergy 1992;22:897-906.
2. 2. PLATTS-MILLS TAE, VERVLOET D, THOMAS WR, AALBERSE RC, CHAPMAN MD. Indoor allergens and asthma. Report of the third international workshop. J Allergy Clin Immunol 1997;100:S1-S24.
3. 3. WEEKS J, OLIVER J, BIRMINGHAM K, CREWES A, CARSWELL F. A combined approach to reduce mite allergen in the bedroom. Clin Exp Allergy 1995;25:1179-1183.
4. 4. FREDERICK JM, WARNER JO, JESSOP WJ, ENANDER I, WARNER JA. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 1997;10:361-366.
5. 5. VARNEY VA, GAGA M, FREW AJ, ABER VR, KAY AB, DURHAM SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-269.
6. 6. BOUSQUET J, MICHEL F. Immunotherapy in rhinitis. In: MYGIND N, NACLERIO R, editors. Allergic and non-allergic rhinitis; clinical aspects. Copenhagen: Munksgaard, 1992:136-148.
7. 7. BOUSQUET J, HEJJAOUI A, MICHEL FB. Specific immunotherapy in asthma. J Allergy Clin Immunol 1990;86:292-305.
8. 8. ABRAMSON MJ, PUY RM, WEINER JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995;151:969-974.
9. 9. REID MJ, LOCKEY RF, TURKELTAUB PC, BUKANZ SC. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92:6-15.
10. 10. MALLING H-J, WEEKE B, editors. EAACI position paper. Immunotherapy. Allergy 1993;48 Suppl 14:9-45.
11. 11. SABBAH A, HASSOUN S, LE SELLIN J, ANDRÉ C, SICARD H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-313.
12. 12. FELIZIANI V, LATTUADA G, PARMIANI S, DALLIAGLIO PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study. Allergol Immunopathol (Madr) 1995;23:224-230.
13. 13. CLAVEL R, BOUSQUET J, ANDRÉ C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass pollen extract in rhinitis. Allergy 1998;53:493-498.
14. 14. TROISE C, VOLTOLINI S, CANESSA A, PECORA S, NEGRINI AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double-blind study. J Investig Allergol Clin Immunol 1995;5:25-30.
15. 15. VOURDAS D, SYRIGOU E, POTAMIANOU P, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662-672.
16. 16. TARI MG, MANCINO M, MONTI G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mites. A double-blind study. Allergol Immunopathol (Madr) 1990;18:277-284.
17. 17. PASSALACQUA G, ALBANO M, FREGONESE L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-632.
18. 18. BOUSQUET J, LOCKEY RF, MALLING H-J, editors. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998,53 Suppl 44:1-42.
19. 19. QUOIX E, LE MAO J, HOYET C, PAULI G. Prediction of mite allergen levels by guanine measurements in house-dust samples. Allergy 1993;48:306-309.
20. 20. MALLING H-J. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-472.
21. 21. EWAN PW, ALEXANDER MM, SNAPE C, IND PW, AGRELL B, DREBORG S. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 1988;18:501-508.
22. 22. MCHUGH SM, LAVELLE B, KEMENY DM, et al. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgG, and IgG subclasses. J Allergy Clin Immunol 1990;86:521-531.
23. 23. HIRSCH TH, SAHN M, LEOPOLD W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8:21-27.
24. 24. BOUSQUET J, SCHEINMANN P, GUINNEPAIN MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;55:249-260.
25. 25. SENSI L, PIANCENTINI G, NOBILE E, et al. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels. Clin Exp Allergy 1994;24:377-382.